Skip to main content
OpenTrials
Completed

NCT Number: NCT03849625

Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand

Study clinical characteristics and phenotypes of patients diagnosed with NSAID sensitivity in Thailand

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Thai patients with a history of an immediate reaction to aspirin/paracetamol, or NSAIDs visiting King Chulalongkorn memorial Hospital

Exclusion criteria

  • None

Treatment and study plan

aspirin, NSAIDs, paracetamol

Drug

Perform skin test and/or provocation test with aspirin, paracetmol, or suspected NSAIDs in questionable cases

Primary outcomes

  1. Results of skin test/provocation test

    Time frame: 4 years

    Positive, negative, or equivocal

Secondary outcomes

  1. Phenotypes of allergic reactions

    Time frame: 4 years

  2. Urine leukotriene E4

    Time frame: 4 years

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Registry information

Important dates

Study start
2015
Primary completion
2020
Study completion
2020
First posted
Feb 21, 2019
Registry last updated
Feb 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.